Skip to main content
Clinical Trials/EUCTR2021-000360-30-FI
EUCTR2021-000360-30-FI
Active, not recruiting
Phase 1

Determination of serum paracetamol concentration with an electrochemical measurement tool from blood and saliva samples in patients using also other medication.

Helsinki University Hospital0 sites20 target enrollmentApril 20, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Patients with any medical condition that requires regular medication and who are undergoing elective surgery.
Sponsor
Helsinki University Hospital
Enrollment
20
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 20, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Helsinki University Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 18\-75 yrs
  • At least one medical condition that requires regular medication (American Society of Anesthesiology (ASA) Classification 2\-4\)
  • Elective surgery, planned premedication with paracetamol
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 15
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 5

Exclusion Criteria

  • Age under 18 or over 76 yrs.
  • Pregnancy, lactation.
  • Alcohol abuse
  • Liver disease that prevents use of paracetamol as premedication for surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials